The use of tetraethylammonium in peripheral vascular disease and causalgic states; a new method for producing blockade of the autonomic ganglion.
BERRY
R L
RL
CAMPBELL
K N
KN
D000641:Ammonia; D064751:Ammonium Compounds; D000765:Anesthesia, Conduction; D001965:Bromides; D002318:Cardiovascular Diseases / Q000628:therapy*; D002422:Causalgia; D005121:Extremities; D005725:Ganglia, Autonomic; D006801:Humans; D009437:Neuralgia; D016491:Peripheral Vascular Diseases; D000644:Quaternary Ammonium Compounds; D019789:Tetraethylammonium
D064751:Ammonium Compounds; D001965:Bromides; D000644:Quaternary Ammonium Compounds; C421484:ethylammonium; D019789:Tetraethylammonium; D000641:Ammonia